Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (51)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Smith, M. K.
Right arrow Articles by Gilmour, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, M. K.
Right arrow Articles by Gilmour, S. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1409-1415, Copyright © 1998 by Oxford University Press


ARTICLES

Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin

MK Smith, CS Trempus and SK Gilmour
Lankenau Medical Research Center, Wynnewood, PA 19096, USA.

Ornithine decarboxylase (ODC) is aberrantly regulated in tumor cells and results in high basal levels of ODC and polyamines in many epithelial tumors. To determine if elevated ODC/polyamine levels can co- operate with a mutant Ha-ras gene in mouse skin tumorigenesis, double transgenic mice were generated by breeding K6/ODC transgenic mice with TG.AC v-Ha-ras transgenic mice. A K6 keratin promoter drives the ODC transgene in K6/ ODC transgenic mice, which results in elevated ODC/ polyamine levels directed to the outer root sheath cells of hair follicles. TG.AC transgenic mice carry a v-Ha-ras transgene while still retaining two normal c-Ha-ras alleles. Transgenic mice that possess only the K6/ODC or the v-Ha-ras transgene did not develop tumors unless treated with either a carcinogen or a tumor promoter, respectively. However, a high percentage of double transgenic mice possessing both the K6/ODC and v-Ha-ras transgenes developed spontaneous tumors. All tumors were well-differentiated keratoacanthomas, some of which progressed to carcinomas within 2 months. The development and the maintenance of these ODC/ras tumors was ODC-dependent since alpha- difluoromethylornithine (DFMO), a specific ODC inhibitor, prevented the formation and caused the regression of these tumors. These findings indicate that ODC overexpression and an activated Ha-ras are sufficient to produce a high rate of malignant transformation in an animal model. The ODC/ras double transgenic mouse provides a simple in vivo model without the use of chemical carcinogens or tumor promoters in which to test downstream effectors that play a key role in mediating the development of epithelial tumors resulting from the cooperation between ODC and v-Ha-ras.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
N. F. Evageliou and M. D. Hogarty
Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
Clin. Cancer Res., October 1, 2009; 15(19): 5956 - 5961.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. J. Rounbehler, W. Li, M. A. Hall, C. Yang, M. Fallahi, and J. L. Cleveland
Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
Cancer Res., January 15, 2009; 69(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Wei, K. DeFeo, C. S. Hayes, P. M. Woster, L. Mandik-Nayak, and S. K. Gilmour
Elevated Ornithine Decarboxylase Levels Activate Ataxia Telangiectasia Mutated-DNA Damage Signaling in Normal Keratinocytes
Cancer Res., April 1, 2008; 68(7): 2214 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. R. Saunders and E. Verdin
Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors.
Mol. Cancer Ther., November 1, 2006; 5(11): 2777 - 2785.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. A. Hobbs, G. Wei, K. DeFeo, B. Paul, C. S. Hayes, and S. K. Gilmour
Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase
Cancer Res., August 15, 2006; 66(16): 8116 - 8122.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. J. Feith, S. Origanti, P. L. Shoop, S. Sass-Kuhn, and L. M. Shantz
Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis
Carcinogenesis, May 1, 2006; 27(5): 1090 - 1098.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. M. Curtin, M. Hanausek, Z. Walaszek, R. Zoltaszek, J. E. Swauger, A. T. Mosberg, and T. J. Slaga
Short-Term Biomarkers of Cigarette Smoke Condensate Tumor Promoting Potential in Mouse Skin
Toxicol. Sci., January 1, 2006; 89(1): 66 - 74.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Nie, W. Feng, R. Diaz, M. A. Gratton, K. J. Doyle, and E. N. Yamoah
Functional Consequences of Polyamine Synthesis Inhibition by L-{alpha}-Difluoromethylornithine (DFMO): CELLULAR MECHANISMS FOR DFMO-MEDIATED OTOTOXICITY
J. Biol. Chem., April 15, 2005; 280(15): 15097 - 15102.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Guo, J. L. Cleveland, and T. G. O'Brien
Haploinsufficiency for Odc Modifies Mouse Skin Tumor Susceptibility
Cancer Res., February 15, 2005; 65(4): 1146 - 1149.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Paul, C. S. Hayes, A. Kim, M. Athar, and S. K. Gilmour
Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice
Carcinogenesis, January 1, 2005; 26(1): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
F. D. Sistare, K. L. Thompson, R. Honchel, and J. DeGeorge
Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals--Practical Pointers, Mechanistic Clues, and New Questions
International Journal of Toxicology, January 1, 2002; 21(1): 65 - 79.
[Abstract] [PDF]


Home page
Cancer Res.Home page
C. A. Hobbs, B. A. Paul, and S. K. Gilmour
Deregulation of Polyamine Biosynthesis Alters Intrinsic Histone Acetyltransferase and Deacetylase Activities in Murine Skin and Tumors
Cancer Res., January 1, 2002; 62(1): 67 - 74.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French
Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice
Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Ahmad, A. C. Gilliam, S. K. Katiyar, T. G. O'Brien, and H. Mukhtar
A Definitive Role of Ornithine Decarboxylase in Photocarcinogenesis
Am. J. Pathol., September 1, 2001; 159(3): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Feith, L. M. Shantz, and A. E. Pegg
Targeted Antizyme Expression in the Skin of Transgenic Mice Reduces Tumor Promoter Induction of Ornithine Decarboxylase and Decreases Sensitivity to Chemical Carcinogenesis
Cancer Res., August 1, 2001; 61(16): 6073 - 6081.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Lan, C. Trempus, and S. K. Gilmour
Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice
Cancer Res., October 1, 2000; 60(20): 5696 - 5703.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. A. Otieno and T. W. Kensler
A Role for Protein Kinase C-{{delta}} in the Regulation of Ornithine Decarboxylase Expression by Oxidative Stress
Cancer Res., August 1, 2000; 60(16): 4391 - 4396.
[Abstract] [Full Text]


Home page
Cell Growth Differ.Home page
S. K. Gilmour, M. Birchler, M. K. Smith, K. Rayca, and J. Mostochuk
Effect of Elevated Levels of Ornithine Decarboxylase on Cell Cycle Progression in Skin
Cell Growth Differ., November 1, 1999; 10(11): 739 - 748.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Wang, W. Devereux, T. M. Stewart, and R. A. Casero Jr.
Cloning and Characterization of Human Polyamine-modulated Factor-1, a Transcriptional Cofactor That Regulates the Transcription of the Spermidine/Spermine N1-Acetyltransferase Gene
J. Biol. Chem., July 30, 1999; 274(31): 22095 - 22101.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.